These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34031132)

  • 1. Precursor Abundance Influences Divergent Antigen-Specific CD8
    Zhang Y; Qiu Z; Sheridan BS; Bliska JB
    Infect Immun; 2021 Jul; 89(8):e0026521. PubMed ID: 34031132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.
    Zhang Y; Mena P; Romanov G; Lin JS; Smiley ST; Bliska JB
    Infect Immun; 2012 Jan; 80(1):206-14. PubMed ID: 22064714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR2+ Inflammatory Dendritic Cells and Translocation of Antigen by Type III Secretion Are Required for the Exceptionally Large CD8+ T Cell Response to the Protective YopE69-77 Epitope during Yersinia Infection.
    Zhang Y; Tam JW; Mena P; van der Velden AW; Bliska JB
    PLoS Pathog; 2015 Oct; 11(10):e1005167. PubMed ID: 26468944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8(+) T cells specific to a single Yersinia pseudotuberculosis epitope restrict bacterial replication in the liver but fail to provide sterilizing immunity.
    Shen H; Gonzalez-Juarbe N; Blanchette K; Crimmins G; Bergman MA; Isberg RR; Orihuela CJ; Dube PH
    Infect Genet Evol; 2016 Sep; 43():289-96. PubMed ID: 27268148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR2
    Zhang Y; Khairallah C; Sheridan BS; van der Velden AWM; Bliska JB
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effector CD8+ T cells are generated in response to an immunodominant epitope in type III effector YopE during primary Yersinia pseudotuberculosis infection.
    Zhang Y; Mena P; Romanov G; Bliska JB
    Infect Immun; 2014 Jul; 82(7):3033-44. PubMed ID: 24799630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YopE specific CD8+ T cells provide protection against systemic and mucosal Yersinia pseudotuberculosis infection.
    González-Juarbe N; Shen H; Bergman MA; Orihuela CJ; Dube PH
    PLoS One; 2017; 12(2):e0172314. PubMed ID: 28207901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8(+) T cells restrict Yersinia pseudotuberculosis infection: bypass of anti-phagocytosis by targeting antigen-presenting cells.
    Bergman MA; Loomis WP; Mecsas J; Starnbach MN; Isberg RR
    PLoS Pathog; 2009 Sep; 5(9):e1000573. PubMed ID: 19730693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
    Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
    Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated Yersinia pseudotuberculosis carrier vaccine for simultaneous antigen-specific CD4 and CD8 T-cell induction.
    Rüssmann H; Gerdemann U; Igwe EI; Panthel K; Heesemann J; Garbom S; Wolf-Watz H; Geginat G
    Infect Immun; 2003 Jun; 71(6):3463-72. PubMed ID: 12761131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.
    Daniel C; Titecat M; Poiret S; Cayet D; Boutillier D; Simonet M; Sirard JC; Lemaître N; Sebbane F
    Vaccine; 2016 Nov; 34(47):5762-5767. PubMed ID: 27742220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
    Viboud GI; Mejía E; Bliska JB
    Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yersinia pseudotuberculosis supports Th17 differentiation and limits de novo regulatory T cell induction by directly interfering with T cell receptor signaling.
    Pasztoi M; Bonifacius A; Pezoldt J; Kulkarni D; Niemz J; Yang J; Teich R; Hajek J; Pisano F; Rohde M; Dersch P; Huehn J
    Cell Mol Life Sci; 2017 Aug; 74(15):2839-2850. PubMed ID: 28378044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the Yersinia pseudotuberculosis Virulence Plasmid in Pathogen-Phagocyte Interactions in Mesenteric Lymph Nodes.
    Bliska JB; Brodsky IE; Mecsas J
    EcoSal Plus; 2021 Dec; 9(2):eESP00142021. PubMed ID: 34910573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White Adipose Tissue Is a Reservoir for Memory T Cells and Promotes Protective Memory Responses to Infection.
    Han SJ; Glatman Zaretsky A; Andrade-Oliveira V; Collins N; Dzutsev A; Shaik J; Morais da Fonseca D; Harrison OJ; Tamoutounour S; Byrd AL; Smelkinson M; Bouladoux N; Bliska JB; Brenchley JM; Brodsky IE; Belkaid Y
    Immunity; 2017 Dec; 47(6):1154-1168.e6. PubMed ID: 29221731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.
    Rüssmann H; Panthel K; Köhn B; Jellbauer S; Winter SE; Garbom S; Wolf-Watz H; Hoffmann S; Grauling-Halama S; Geginat G
    Infect Immun; 2010 Dec; 78(12):5138-50. PubMed ID: 20876292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yersinia pseudotuberculosis efficiently escapes polymorphonuclear neutrophils during early infection.
    Westermark L; Fahlgren A; Fällman M
    Infect Immun; 2014 Mar; 82(3):1181-91. PubMed ID: 24379291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.
    McPhee JB; Mena P; Zhang Y; Bliska JB
    Infect Immun; 2012 Jul; 80(7):2519-27. PubMed ID: 22547545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proinflammatory microenvironments within the intestine regulate the differentiation of tissue-resident CD8⁺ T cells responding to infection.
    Bergsbaken T; Bevan MJ
    Nat Immunol; 2015 Apr; 16(4):406-14. PubMed ID: 25706747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Killer Cells Mediate Protection against Yersinia pseudotuberculosis in the Mesenteric Lymph Nodes.
    Rosenheinrich M; Heine W; Schmühl CM; Pisano F; Dersch P
    PLoS One; 2015; 10(8):e0136290. PubMed ID: 26296209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.